Jean‐Michel Franconi
Papers
1
Total Citations
30
H-Index
1
About
Jean‑Michel Franconi is a pioneering researcher whose work bridges molecular imaging, antibody engineering, and cardiovascular disease. His key research areas include the development of targeted molecular probes for atherosclerosis, phage-display antibody technology, and in vivo biopanning strategies. Franconi’s major contribution lies in the innovative design of a two-step in vivo biopanning method to rapidly isolate human monoclonal phage-display single-chain antibodies (MoPhabs) that home specifically to early atherosclerotic lesions. This approach, detailed in his highly cited 2006 paper “Identification of Human scFvs Targeting Atherosclerotic Lesions” (30 citations), opened new avenues for non-invasive imaging and targeted therapy of cardiovascular disease. By enabling the identification of human antibodies reactive with diseased vascular regions, Franconi’s work has provided a powerful platform for developing diagnostic and therapeutic agents that precisely target pathological tissues. His research has significant implications for early detection and treatment of atherosclerosis, a leading cause of morbidity worldwide. Franconi’s achievements demonstrate a unique ability to combine cutting-edge antibody engineering with in vivo selection strategies, advancing the field of molecular medicine and offering promising tools for future clinical applications.
Research Focus
Key Achievements
Top Papers
- 1Identification of Human scFvs Targeting Atherosclerotic Lesions30 citations · 2006